Article
Elongin BC complex negatively regulates AXL and marks a differentiated phenotype in melanoma
2022-07-29
Abstract excerpt
<title>Abstract</title> <p>High expression of the receptor tyrosine kinase AXL is implicated in epithelial-to-mesenchymal transition, cancer progression and therapy resistance. For example, AXL is abundant in BRAF mutant melanomas progressing on targeted BRAF/MEK inhibition. Therefore, AXL is thought to represent an attractive therapeutic target. This notwithstanding, little is known about the mechanisms governin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 171f1c1e-2386-5c89-ae1d-0b9832ab3b1b
- DOI
- 10.21203/rs.3.rs-1808665/v1
